Robert Durkin

Robert Durkin

Arnall Golden Gregory LLP

Contact
View Bio
RSS

Latest Posts › Medical Devices

Share:

AGG Food & Drug Newsletter - November 2021

Arnall Golden Gregory LLP's Food & Drug Newsletter is a monthly update of legal and regulatory issues that affect the FDA-regulated community and highlights articles from members of our Food & Drug practice, as well as from...more

11/23/2021  /  Anti-Kickback Statute , Food and Drug Administration (FDA) , Medical Devices , Pharmaceutical Industry , Prescription Drugs

AGG Food & Drug Newsletter - May 2021

Arnall Golden Gregory LLP's Food & Drug Newsletter is a monthly update of legal and regulatory issues that affect the FDA-regulated community and highlights articles from members of our Food & Drug practice, as well as from...more

5/28/2021  /  False Claims Act (FCA) , Food and Drug Administration (FDA) , Medical Devices , Noncompliance , Off-Label Use

AGG Food & Drug Newsletter - October 2020

Arnall Golden Gregory LLP's Food and Drug Newsletter is a monthly update of legal and regulatory issues that affect the FDA-regulated community and highlights articles from members of AGG outside the Food and Drug practice....more

10/30/2020  /  Dietary Supplements , Emergency Use Authorization (EUA) , Food and Drug Administration (FDA) , Food Labeling , Imports , Manufacturers , Medical Devices , Nutrition Facts Labels , Pharmaceutical Industry , Prescription Drugs

FDA Issues Proposed Rule Seeking to Clarify Evidence Relevant to Its Intended Use Determinations of FDA-Regulated Products

On September 23, 2020, the U.S. Food and Drug Administration (FDA) published in the Federal Register a proposed rule titled, “Regulations Regarding ‘Intended Uses.’”...more

10/1/2020  /  Food and Drug Administration (FDA) , Intended Use , Manufacturers , Medical Devices , Product Labels , Regulatory Requirements

AGG Food & Drug Newsletter - July 2020

Arnall Golden Gregory LLP's Food and Drug Newsletter is a monthly update of legal and regulatory issues that affect the FDA-regulated community and highlights articles from members of AGG outside the Food and Drug practice....more

7/29/2020  /  Cannabidiol (CBD) oil , Clinical Trials , Coronavirus/COVID-19 , Food and Drug Administration (FDA) , Life Sciences , Medical Devices , Misbranding , Pharmaceutical Industry , Prescription Drugs

AGG Food & Drug Newsletter - June 2020

Arnall Golden Gregory LLP's Food and Drug Newsletter is a monthly update of legal and regulatory issues that affect the FDA-regulated community and highlights articles from members of AGG outside the Food and Drug practice....more

7/6/2020  /  Coronavirus/COVID-19 , Dietary Supplements , Medical Devices , Medical Supplies , Pharmaceutical Industry , Prescription Drugs , Price-Fixing

AGG Food & Drug Newsletter - April 2020

Arnall Golden Gregory LLP's Food and Drug Newsletter is a monthly update of legal and regulatory issues that affect the FDA-regulated community and highlights articles from members of AGG outside the Food and Drug practice....more

5/7/2020  /  CARES Act , Coronavirus/COVID-19 , Food and Drug Administration (FDA) , Medical Devices , Over The Counter Drugs (OTC)

AGG Food & Drug Newsletter - January 2020

Arnall Golden Gregory LLP's Food and Drug Newsletter is a monthly update of legal and regulatory issues that affect the FDA-regulated community and highlights articles from members of AGG outside the Food and Drug Practice....more

1/24/2020  /  510(k) RTA , California Consumer Privacy Act (CCPA) , Data Collection , Data Privacy , Food and Drug Administration (FDA) , Medical Devices , Nutrition Facts Labels , Personal Information
8 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide